Cargando…

Association of TNFRSF12A Methylation With Prognosis in Hepatocellular Carcinoma With History of Alcohol Consumption

Hepatocellular carcinoma (HCC) is the third leading cause of cancer related death worldwide with a poor prognosis. Alcoholic liver disease accounts for approximately one-third of all HCC cases. Current evidence proved that aberrant over-expression of TNFRSF12A correlates with the severity of disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yi, Zhang, Sina, Xie, Xiaozai, Chen, Ziyan, Wu, Lijun, Yu, Zhengping, Guo, Xiaojuan, Chen, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964049/ https://www.ncbi.nlm.nih.gov/pubmed/31998364 http://dx.doi.org/10.3389/fgene.2019.01299

Ejemplares similares

A Null Mutation of TNFRSF11A Causes Dysosteosclerosis, Not Osteopetrosis
por: Kırkgöz, Tarık, et al.
Publicado: (2022)

A FITM1-Related Methylation Signature Predicts the Prognosis of Patients With Non-Viral Hepatocellular Carcinoma
por: Chen, Jie, et al.
Publicado: (2020)

TNFRSF12A and a new prognostic model identified from methylation combined with expression profiles to predict overall survival in hepatocellular carcinoma
por: Fang, Yu, et al.
Publicado: (2020)

Smoking, alcohol consumption, and frailty: A Mendelian randomization study
por: Lv, Jiannan, et al.
Publicado: (2023)

Tumor Necrosis Factor Receptor SF10A (TNFRSF10A) SNPs Correlate With Corticosteroid Response in Duchenne Muscular Dystrophy
por: Passarelli, Chiara, et al.
Publicado: (2020)

Protective Effect of TNFRSF11A rs7239667 G > C Gene Polymorphism on Coronary Outcome of Kawasaki Disease in Southern Chinese Population
por: Zhang, Linyuan, et al.
Publicado: (2021)

Knockdown of the differentially expressed gene TNFRSF12A inhibits hepatocellular carcinoma cell proliferation and migration in vitro
por: Wang, Tao, et al.
Publicado: (2017)

The role of tumour microenvironment: a new vision for cholangiocarcinoma
por: Chen, Ziyan, et al.
Publicado: (2018)

Development and Validation of a Pyroptosis-Related Signature for Predicting Prognosis in Hepatocellular Carcinoma
por: Ding, Jianfeng, et al.
Publicado: (2022)

Analysis of eight types of RNA modification regulators and their correlation with the prognosis in hepatocellular carcinoma
por: Qin, Wan, et al.
Publicado: (2023)

Alcohol consumption and colorectal cancer risk: A mendelian randomization study
por: Li, Yuwei, et al.
Publicado: (2022)

Association of TNFRSF10D DNA-Methylation with the Survival of Melanoma Patients
por: Ratzinger, Gudrun, et al.
Publicado: (2014)

Identification and analysis of DNA methylation-driven signatures for prognostic and immune microenvironments evaluation in hepatocellular carcinoma
por: Shen, Bingbing, et al.
Publicado: (2022)

Development and Validation of an Immune-Related lncRNA Signature for Predicting the Prognosis of Hepatocellular Carcinoma
por: Kong, Weihao, et al.
Publicado: (2020)

Elevated Expression of PDZD11 Is Associated With Poor Prognosis and Immune Infiltrates in Hepatocellular Carcinoma
por: Chen, Yao, et al.
Publicado: (2021)

Synergistic Effect of Lenvatinib and Chemotherapy in Hepatocellular Carcinoma Using Preclinical Models
por: Wang, Mingxun, et al.
Publicado: (2023)

Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma
por: Qi, Li-Wen, et al.
Publicado: (2021)

Decreased expression of TNFRSF12A in thyroid gland cancer predicts poor prognosis: A study based on TCGA data
por: Wu, Zeng-Hong, et al.
Publicado: (2020)

Identification and Validation of Necroptosis-Related LncRNA Signature in Hepatocellular Carcinoma for Prognosis Estimation and Microenvironment Status
por: Chen, Cong, et al.
Publicado: (2022)

Identification and validation of TNFRSF4 as a high-profile biomarker for prognosis and immunomodulation in endometrial carcinoma
por: Ma, Heng, et al.
Publicado: (2022)

Prognosis-Predictive Signature and Nomogram Based on Autophagy-Related Long Non-coding RNAs for Hepatocellular Carcinoma
por: Jia, Yu, et al.
Publicado: (2020)

TNFRSF10C methylation is a new epigenetic biomarker for colorectal cancer
por: Zhou, Cong, et al.
Publicado: (2018)

Identification of Hub Genes Associated With Immune Infiltration and Predict Prognosis in Hepatocellular Carcinoma via Bioinformatics Approaches
por: Chen, Huaping, et al.
Publicado: (2021)

DNA Methylation and Hydroxymethylation in Cervical Cancer: Diagnosis, Prognosis and Treatment
por: Zhu, Hongming, et al.
Publicado: (2020)

Identification and verification of a novel epigenetic-related gene signature for predicting the prognosis of hepatocellular carcinoma
por: Wang, Chenchen, et al.
Publicado: (2022)

A Seven-Gene Signature to Predict Prognosis of Patients With Hepatocellular Carcinoma
por: Wang, Junli, et al.
Publicado: (2021)

A necroptosis -related signature for predicting prognosis and immunotherapy in hepatocellular carcinoma
por: Fu, Xing, et al.
Publicado: (2022)

µ-Opioid Receptor Gene (OPRM1) Polymorphism A118G: Lack of Association in Finnish Populations with Alcohol Dependence or Alcohol Consumption
por: Rouvinen-Lagerström, Noora, et al.
Publicado: (2013)

A novel five-lncRNA signature panel improves high-risk survival prediction in patients with cholangiocarcinoma
por: Xie, Xiaozai, et al.
Publicado: (2021)

Key genes associated with non-alcoholic fatty liver disease and hepatocellular carcinoma with metabolic risk factors
por: Yang, Fan, et al.
Publicado: (2023)

Cancer stemness-associated LINC02475 serves as a novel biomarker for diagnosis and prognosis prediction of hepatocellular carcinoma
por: Lin, Xian, et al.
Publicado: (2022)

Maternal trauma and fear history predict BDNF methylation and gene expression in newborns
por: Pilkay, Stefanie R., et al.
Publicado: (2020)

The Impact of Recent Alcohol Use on Genome Wide DNA Methylation Signatures
por: Philibert, Robert A., et al.
Publicado: (2012)

Identification of a nucleotide metabolism-related signature to predict prognosis and guide patient care in hepatocellular carcinoma
por: Li, Yu, et al.
Publicado: (2023)

Stemness analysis in hepatocellular carcinoma identifies an extracellular matrix gene–related signature associated with prognosis and therapy response
por: Chen, Lei, et al.
Publicado: (2022)

Recognition of DNA Methylation Molecular Features for Diagnosis and Prognosis in Gastric Cancer
por: Liu, Donghui, et al.
Publicado: (2021)

The Co-occurrence of Chronic Hepatitis B and Fibrosis Is Associated With a Decrease in Hepatic Global DNA Methylation Levels in Patients With Non-alcoholic Fatty Liver Disease
por: Li, FangYuan, et al.
Publicado: (2021)

Comprehensive analysis of SLC43A2 on the tumor immune microenvironment and prognosis of liver hepatocellular carcinoma
por: Liao, Yan, et al.
Publicado: (2022)

The Identification of Critical m(6)A RNA Methylation Regulators as Malignant Prognosis Factors in Prostate Adenocarcinoma
por: Xu, Jiaju, et al.
Publicado: (2020)

The pattern of expression and prognostic value of key regulators for m(7)G RNA methylation in hepatocellular carcinoma
por: Chen, Jianxing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5aasr87v72qukpvsggn009hnst